TNY scientific meeting April 2026

Welcome address

An audit of Hospital Point Of Care (POC) INR testing in the age of Direct Oral Anticoagulants (DOACs)

• Maria De Ferrars, principal clinical scientist

Is metabolic testing indicated in the first-line investigation of paediatric fatty liver?
A literature review, workload analysis and cost estimation following the publication of the BSPGHAN fatty liver guideline

• Ann Bowron, consultant clinical scientist

Are our urate reference intervals fit for the paediatric population?

• Madhusha Pathirana, trust doctor in chemical pathlogy

Prevalence of Non-toxigenic Corynebacterium diphtheriae in vulnerable patient groups in Hull and East Yorkshire 2022-2026

• Phillipa Burns, consultant clinical scientist
• Alexander Richards, MD student

Exploring local epidemiology of Clostridioides difficile: an audit incorporating UKHSA sentinel surveillance data

• Kerry-Anne Revie, trainee clinical scientist

Ambient ammonia analysis - Does it matter?

• Ailsa Ralph, senior clinical scientist

Clinical audit assessing the utility of urine electrophoresis (“Bence Jones Protein” testing) in laboratory screening for Multiple Myeloma

• Stephanie Laba, clinical scientist